Maryland Clinical Research Coordinator
Certification Exam Practice Questions
And Correct Answers (Verified Answers)
Plus Rationale 2026 Q&A| Instant
Download Pdf
1. Which of the following best describes the primary role of a Clinical
Research Coordinator (CRC) in a clinical trial setting?
A. Independently designing clinical trial protocols and determining statistical
endpoints
B. Managing day-to-day study operations under the supervision of the
Principal Investigator while ensuring compliance with protocol and
regulations
C. Approving investigational new drug applications submitted to regulatory
authorities
D. Performing final data analysis and publishing study results as lead author
The correct answer is B because a Clinical Research Coordinator primarily
supports the Principal Investigator by organizing and managing daily trial
activities, ensuring adherence to protocols, and maintaining regulatory
compliance rather than independently designing studies or performing
final analysis.
, 2. Which regulatory framework most directly governs the ethical conduct
of human subject research in clinical trials?
A. HIPAA Privacy Rule
B. Good Clinical Practice (GCP) guidelines under ICH E6
C. OSHA laboratory safety standards
D. Sarbanes-Oxley Act
The correct answer is B because ICH Good Clinical Practice (GCP) provides
internationally recognized ethical and scientific quality standards for
designing, conducting, recording, and reporting clinical trials involving
human subjects.
3. In clinical research, what is the primary purpose of informed consent?
A. To guarantee participants will benefit from the investigational treatment
B. To allow sponsors to collect identifiable participant data freely
C. To ensure participants voluntarily agree to participate after understanding
risks, benefits, and alternatives
D. To replace Institutional Review Board (IRB) approval
The correct answer is C because informed consent ensures that participants
make a voluntary, informed decision about participation after
understanding all relevant aspects of the study.
4. Which of the following best defines a protocol deviation in a clinical
trial?
A. Any change to the study design approved by the sponsor before initiation
B. A planned amendment to eligibility criteria submitted to the IRB
C. A departure from the approved protocol that does not affect participant
safety or data integrity
D. A complete termination of the clinical trial by regulatory authorities
,The correct answer is C because a protocol deviation refers to an
unintentional departure from the approved protocol procedures, often
minor, that does not necessarily compromise participant safety or overall
study validity.
5. What is the primary function of an Institutional Review Board (IRB)?
A. To market investigational drugs to healthcare providers
B. To ensure financial profitability of clinical trials
C. To review, approve, and monitor research involving human subjects to
protect their rights and welfare
D. To perform laboratory testing of investigational products
The correct answer is C because the IRB is responsible for protecting human
subjects by reviewing study protocols, informed consent documents, and
ongoing research activities to ensure ethical standards are met.
6. Which document serves as the primary blueprint for conducting a
clinical trial?
A. Case Report Form (CRF)
B. Study protocol
C. Informed consent form
D. Monitoring report
The correct answer is B because the study protocol outlines all procedures,
objectives, methodology, and operational details required to conduct a
clinical trial consistently and correctly.
7. What is the main purpose of source documentation in clinical
research?
A. To replace regulatory submission requirements
B. To provide raw, original records that verify data entered into case report
forms
, C. To advertise study results to stakeholders
D. To eliminate the need for monitoring visits
The correct answer is B because source documents provide the original,
verifiable evidence of trial data, ensuring accuracy and traceability
between patient records and reported study data.
8. Which phase of clinical trials primarily focuses on determining safety,
dosage, and side effects in a small group of participants?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
The correct answer is A because Phase I trials are conducted in small
groups to evaluate safety, tolerability, pharmacokinetics, and appropriate
dosage ranges.
9. What is a Serious Adverse Event (SAE) in clinical research?
A. Any mild headache reported by a participant
B. A laboratory value within normal limits
C. An event that results in death, life-threatening conditions, hospitalization,
or significant disability
D. Any protocol amendment requested by the sponsor
The correct answer is C because a Serious Adverse Event is defined by
outcomes that pose significant risk to participant health, including death,
hospitalization, or life-threatening conditions.
10. What is the primary purpose of randomization in clinical trials?
A. To ensure only healthy participants are enrolled
B. To eliminate all side effects from investigational drugs
C. To reduce selection bias by assigning participants to study groups by
Certification Exam Practice Questions
And Correct Answers (Verified Answers)
Plus Rationale 2026 Q&A| Instant
Download Pdf
1. Which of the following best describes the primary role of a Clinical
Research Coordinator (CRC) in a clinical trial setting?
A. Independently designing clinical trial protocols and determining statistical
endpoints
B. Managing day-to-day study operations under the supervision of the
Principal Investigator while ensuring compliance with protocol and
regulations
C. Approving investigational new drug applications submitted to regulatory
authorities
D. Performing final data analysis and publishing study results as lead author
The correct answer is B because a Clinical Research Coordinator primarily
supports the Principal Investigator by organizing and managing daily trial
activities, ensuring adherence to protocols, and maintaining regulatory
compliance rather than independently designing studies or performing
final analysis.
, 2. Which regulatory framework most directly governs the ethical conduct
of human subject research in clinical trials?
A. HIPAA Privacy Rule
B. Good Clinical Practice (GCP) guidelines under ICH E6
C. OSHA laboratory safety standards
D. Sarbanes-Oxley Act
The correct answer is B because ICH Good Clinical Practice (GCP) provides
internationally recognized ethical and scientific quality standards for
designing, conducting, recording, and reporting clinical trials involving
human subjects.
3. In clinical research, what is the primary purpose of informed consent?
A. To guarantee participants will benefit from the investigational treatment
B. To allow sponsors to collect identifiable participant data freely
C. To ensure participants voluntarily agree to participate after understanding
risks, benefits, and alternatives
D. To replace Institutional Review Board (IRB) approval
The correct answer is C because informed consent ensures that participants
make a voluntary, informed decision about participation after
understanding all relevant aspects of the study.
4. Which of the following best defines a protocol deviation in a clinical
trial?
A. Any change to the study design approved by the sponsor before initiation
B. A planned amendment to eligibility criteria submitted to the IRB
C. A departure from the approved protocol that does not affect participant
safety or data integrity
D. A complete termination of the clinical trial by regulatory authorities
,The correct answer is C because a protocol deviation refers to an
unintentional departure from the approved protocol procedures, often
minor, that does not necessarily compromise participant safety or overall
study validity.
5. What is the primary function of an Institutional Review Board (IRB)?
A. To market investigational drugs to healthcare providers
B. To ensure financial profitability of clinical trials
C. To review, approve, and monitor research involving human subjects to
protect their rights and welfare
D. To perform laboratory testing of investigational products
The correct answer is C because the IRB is responsible for protecting human
subjects by reviewing study protocols, informed consent documents, and
ongoing research activities to ensure ethical standards are met.
6. Which document serves as the primary blueprint for conducting a
clinical trial?
A. Case Report Form (CRF)
B. Study protocol
C. Informed consent form
D. Monitoring report
The correct answer is B because the study protocol outlines all procedures,
objectives, methodology, and operational details required to conduct a
clinical trial consistently and correctly.
7. What is the main purpose of source documentation in clinical
research?
A. To replace regulatory submission requirements
B. To provide raw, original records that verify data entered into case report
forms
, C. To advertise study results to stakeholders
D. To eliminate the need for monitoring visits
The correct answer is B because source documents provide the original,
verifiable evidence of trial data, ensuring accuracy and traceability
between patient records and reported study data.
8. Which phase of clinical trials primarily focuses on determining safety,
dosage, and side effects in a small group of participants?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
The correct answer is A because Phase I trials are conducted in small
groups to evaluate safety, tolerability, pharmacokinetics, and appropriate
dosage ranges.
9. What is a Serious Adverse Event (SAE) in clinical research?
A. Any mild headache reported by a participant
B. A laboratory value within normal limits
C. An event that results in death, life-threatening conditions, hospitalization,
or significant disability
D. Any protocol amendment requested by the sponsor
The correct answer is C because a Serious Adverse Event is defined by
outcomes that pose significant risk to participant health, including death,
hospitalization, or life-threatening conditions.
10. What is the primary purpose of randomization in clinical trials?
A. To ensure only healthy participants are enrolled
B. To eliminate all side effects from investigational drugs
C. To reduce selection bias by assigning participants to study groups by
